Over-expression of CEACAM6 is documented in many human epithelial (e.g. colorectal, breast, pancreatic ductal adenocarcinoma (PDA))6,7 and hematologic malignancies (e.g. multiple myeloma and acute lymphoblastic leukemia)5. This evidence concerns the gene CEACAM6 and AL amyloidosis.